0002019360-24-000001.txt : 20240415 0002019360-24-000001.hdr.sgml : 20240415 20240415161616 ACCESSION NUMBER: 0002019360-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240415 DATE AS OF CHANGE: 20240415 EFFECTIVENESS DATE: 20240415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pierrepont Therapeutics, Inc. CENTRAL INDEX KEY: 0002019360 ORGANIZATION NAME: IRS NUMBER: 851798337 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-510659 FILM NUMBER: 24844829 BUSINESS ADDRESS: STREET 1: DOWNSTATE TECHNOLOGY CENTER, SUITE 327A STREET 2: 760 PARKSIDE AVENUE CITY: BROOKLYN STATE: NY ZIP: 11203 BUSINESS PHONE: 212-430-1740 MAIL ADDRESS: STREET 1: DOWNSTATE TECHNOLOGY CENTER, SUITE 327A STREET 2: 760 PARKSIDE AVENUE CITY: BROOKLYN STATE: NY ZIP: 11203 D 1 primary_doc.xml X0708 D LIVE 0002019360 Pierrepont Therapeutics, Inc. DOWNSTATE TECHNOLOGY CENTER, SUITE 327A 760 PARKSIDE AVENUE BROOKLYN NY NEW YORK 11203 212-430-1740 DELAWARE None None Corporation true 2020 Peter H. Barber c/o Pierrepont Therapeutics, Inc. Downstate Technology Center, Suite 327A Brooklyn NY NEW YORK 11203 Executive Officer Director Daniel DiPietro c/o Pierrepont Therapeutics, Inc. Downstate Technology Center, Suite 327A Brooklyn NY NEW YORK 11203 Director Matthew Wyckoff c/o Pierrepont Therapeutics, Inc. Downstate Technology Center, Suite 327A Brooklyn NY NEW YORK 11203 Director Pharmaceuticals Decline to Disclose 06b false 2024-04-02 false true false 0 5859876 2109876 3750000 false 2 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Pierrepont Therapeutics, Inc. /s/ Peter H. Barber Peter H. Barber President 2024-04-12